Notably, blocking both ICAM-1 and VCAM-1 further decreased survival to levels comparable to T-ALL cells cultured alone (Fig. 2a, Supplementary Fig. 5a, b), indicating that these adhesion molecules are essential for myeloid-mediated T-ALL support. Here, ICAM1 is linked to acute lymphoblastic leukemia.